Synapse - Works

Results (4297)

The Borealis-2 clinical trial: A randomized phase 2 study of OGX-427 (apatorsen) plus docetaxel versus docetaxel alone in relapsed/refractory metastatic urothelial cancer

Meeting Abstract

Choueiri, T. K.; Hahn, N. M.; Pai, S. K.; Alva, A. S.; Drelcer, R.; Starodub, A.; Sonpavde, G.; Hoffman-Censlts, J. H.; Plcus, J.; Baler, A. V.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

The neoantigen landscape underlying clinical response to ipilimumab

Meeting Abstract

Snyder Charen, A.; Makarov, V.; Merghoub, T.; Walsh, L.; Yuan, J.; Miller, M.; Kannan, K.; Postow, M. A.; Elipenahli, C.; Liu, C.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Response rates to hepatic arterial infusion (HAI) pump therapy in patients with metastatic colorectal cancer liver metastases (mCRC LM) after progression on all standard chemotherapies

Meeting Abstract

Cercek, A.; Aguilo, A.; Gluskin, J.; Chou, J. F.; Reidy, D. L.; Saltz, L.; Siegel, C.; Capanu, M.; Jarnagin, W. R.; DeMatteo, R. P.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Trivalent ganglioside vaccine and immunologic adjuvant versus adjuvant alone in metastatic sarcoma patients rendered disease-free by surgery: A randomized phase 2 trial

Meeting Abstract

Carvajal, R. D.; Agulnik, M.; Ryan, C. W.; Milhem, M. M.; George, S.; Jones, R. L.; Chmielowski, B.; Van Tine, B. A.; Tawbi, H. A. H.; Elias, A. D.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Gene expression signatures in pre- and post-therapy (Rx) specimens from CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel and trastuzumab with or without lapatinib for HER2-positive breast cancer (BrCa)

Meeting Abstract

Carey, L. A.; Barry, W. T.; Pitcher, B.; Hoadley, K. A.; Cheang, M. C. U.; Anders, C. K.; Henry, N. L.; Tolaney, S. M.; Dang, C. T.; Krop, I. E.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Development of a patient-reported outcome (PRO) measure for assessing non-small cell lung cancer (NSCLC) symptoms in clinical trials: Interim report from the PRO Consortium's NSCLC Working Group (WG)

Meeting Abstract

Campbell, A. K.; Martin, M. L.; Arduino, J. M.; Atkinson, T. M.; Lundy, J. J.; Lungershausen, J.; Denis, L. J.; Liapa, A. M.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

A phase 1 study to evaluate the safety and tolerability of MEDI4736, an anti-PD-L1 antibody, in combination with tremelimumab in patients with advanced solid tumors

Meeting Abstract

Callahan, M. K.; Ott, P. A.; Odunsi, K.; Bertolini, S. V.; Pan, L. S.; Venhaus, R. R.; Karakunnel, J. J.; Hodi, F. S.; Wolchok, J. D.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Phase I/II, open-label study of nivolumab (anti-PD-1; BMS-936558, ONO-4538) as monotherapy or combined with ipilimumab in advanced or metastatic solid tumors

Meeting Abstract

Callahan, M. K.; Bendell, J. C.; Chan, E.; Morse, M.; Pillai, R. N.; Bono, P.; Jaeger, D.; Evans, T. R. J.; Chau, I.; Calvo, E.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

A virtual consult service to optimize clinical trial participation in patients with metastatic breast cancer

Meeting Abstract

Cadoo, K. A.; Shah, P. D.; Charen, A. S.; Bromberg, J.; Comen, E. A.; D'Andrea, G.; Dang, C. T.; Gilewski, T.; Gucalp, A.; Lake, D.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

A phase 2 study of orally administered PLX3397 in patients with recurrent glioblastoma

Meeting Abstract

Butowski, N. A.; Colman, H.; De Groot, J. F.; Omuro, A. M. P.; Nayak, L.; Cloughesy, T. F.; Marlmuthu, A.; Perry, A.; Phillips, J. J.; West, B.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save